20th Aug 2025 07:00
Condensed Consolidated Statement of Profit or Loss and other Comprehensive Income |
|
| |||||
|
|
|
|
|
|
|
|
|
|
| 30 June 2025 |
| 30 June 2024 |
|
|
|
|
| Shs'000 |
| Shs'000 |
|
|
Sales | 1,511,260 | 1,175,166 | |||||
Profit before fair value gain in non-current biological assets and income tax | 409,666 | 485,583 | |||||
Fair value gain in non-current biological assets | 25,579 | 21,509 | |||||
Profit before income tax | 435,245 | 507,092 | |||||
Income tax expense | (139,707 | ) | (159,581 | ) | |||
Profit for the period | 295,538 | 347,511 | |||||
Other Comprehensive Income | - | - | |||||
Total comprehensive income | 295,538 | 347,511 | |||||
| Shs |
| Shs |
|
| ||
Earnings per share (Shs): |
|
|
|
|
| ||
Basic and diluted earnings per ordinary share | 15.08 | 17.73 | |||||
Condensed Consolidated Statement of Financial Position | ||||||||||
|
|
|
|
|
|
|
|
| Audited |
|
|
|
|
|
| 30 June 2025 |
| 30 June 2024 |
| 31 Dec 2024 |
|
|
|
|
|
| Shs'000 |
| Shs'000 |
| Shs'000 |
|
EQUITY | ||||||||||
Share capital | 98,000 | 98,000 | 98,000 | |||||||
Other reserves | 36,251 | 34,929 | 36,251 | |||||||
Retained earnings | 5,337,797 | 5,678,264 | 5,042,259 | |||||||
Proposed dividends | - | - | 156,800 | |||||||
Total equity | 5,472,048 | 5,811,193 | 5,333,310 | |||||||
Non-current liabilities | 1,303,861 | 1,244,674 | 1,267,964 | |||||||
6,775,909 | 7,055,867 | 6,601,274 | ||||||||
REPRESENTED BY | ||||||||||
Non-current assets | 4,054,964 | 3,986,091 | 4,157,742 | |||||||
Cash assets excluding cash and bank balances |
2,243,123 |
3,456,440 |
1,651,215 | |||||||
Cash and bank balances | 890,293 | 130,377 | 1,106,684 | |||||||
Current liabilities | (412,471 | ) | (517,041 | ) | (314,367 | ) | ||||
Net working capital | 2,720,945 | 3,069,776 | 2,443,532 | |||||||
6,775,909 | 7,055,867 | 6,601,274 | ||||||||
Condensed Consolidated Statement of Cash flows |
|
| |||||
|
|
| 30 June 2025 |
| 30 June 2024 |
|
|
|
|
| Shs'000 |
| Shs'000 |
|
|
Cash and cash equivalents at the beginning of the period | 1,106,684 | 1,408,131 |
| ||||
Net cash used in operating activities | 11,871 | (536,131 | ) | ||||
Net cash used in investing activities | (67,603 | ) | (107,891 | ) | |||
Net cash used in financing activities | (156,861 | ) | (470,400 | ) | |||
Effect of exchange rate differences on cash and cash equivalents |
(3,798 |
) |
(163,332 |
) | |||
Decrease in cash and cash equivalents | (216,391 | ) | (1,277,754 | ) | |||
Cash and cash equivalents at the end of the period | 890,293 | 130,377 | |||||
|
Condensed Consolidated Statement of Changes in Equity |
| ||||||||||
| Share capital |
| Other reserves |
| Retained earnings |
| Proposed dividends |
| Total Equity |
| |
| Shs'000 |
| Shs'000 |
| Shs'000 |
| Shs'000 |
| Shs'000 |
| |
As at 1 January 2025 | 98,000 | 36,251 | 5,042,259 | 156,800 | 5,333,310 | ||||||
Profit for the period | - | - | 295,538 | - | 295,538 | ||||||
Dividends paid | - | - | - | (156,800 | ) | (156,800 | ) | ||||
As at 30 June 2025 | 98,000 | 36,251 | 5,337,797 | - | 5,472,048 | ||||||
|
Related Shares:
Kakuzi